COMPARISON OF SERUM ETHINYL ESTRADIOL, SEX-HORMONE-BINDING GLOBULIN, CORTICOID-BINDING GLOBULIN AND CORTISOL-LEVELS IN WOMEN USING 2 LOW-DOSE COMBINED ORAL-CONTRACEPTIVES

被引:33
作者
HUMPEL, M
TAUBER, U
KUHNZ, W
PFEFFER, M
BRILL, K
HEITHECKER, R
LOUTON, T
STEINBERG, B
机构
[1] Schering AG Research Laboratories, Berlin, Bergkamen
关键词
Contraceptives; Corticoid-binding globulin; Cortisol; Desogestrel; Ethinyl estradiol; Gestodene; Serum hormones; Sex-hormone-binding globulin;
D O I
10.1159/000181445
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The study included 69 women taking a desogestrel (n = 30)- or gestodene (n = 39)-containing low-dose combined oral contraceptive for at least 3 months. Group size was calculated to detect a difference in mean values of 80% of 1 standard deviation (α = 0-05, β = 0.1). Seven serum samples were obtained up to 4 h, and 1 sample 24 h. after drug intake on 1 day between the 10th and the 21 st day of the cycle. The concentrations of sex-hormone-binding globulin (SHBG), corticoid-binding globulin (CBG) and Cortisol were measured in a 0- to 4-hour serum pool by radioimmunoassay. Ethinyl estradiol (EE2) levels were analyzed in single and pooled samples using anti-EE2-6β-carboxymethyloxime-bovine serum albumin antiserum. The area under the curves (AUC) up to 4 and 24 h and Cmax and tmax were evaluated. Statistical analysis (analysis of covariance) did not reveal a dependence of values on duration of treatment or day of cycle. Both treatments resulted in almost identical values for all parameters evaluated. The mean levels of SHBG, CBG and Cortisol were in the range of 186-226 nmol/l, 89-93 mg/l and 280-281 µg/l, respectively. Mean maximum EE2 levels of 106-129 pg/ml were found 1.6-1.8 h after pill intake and AUC0-4 h accounted for 329-374 pg·h·mH. The recently reported differences in serum EE2 and CBG levels between two groups of 11 women each treated with desogestrel- and gestodene-containing pills, respectively, could not be confirmed. © 1990 S. Karger AG, Basel.
引用
收藏
页码:35 / 39
页数:5
相关论文
共 16 条
[1]   THE INTERACTION OF PHENOBARBITAL AND OTHER ANTICONVULSANTS WITH ORAL-CONTRACEPTIVE STEROID-THERAPY [J].
BACK, DJ ;
BATES, M ;
BOWDEN, A ;
BRECKENRIDGE, AM ;
HALL, MJ ;
JONES, H ;
MACIVER, M ;
ORME, M ;
PERUCCA, E ;
RICHENS, A ;
ROWE, PH ;
SMITH, E .
CONTRACEPTION, 1980, 22 (05) :495-503
[2]   INVESTIGATION OF THE PHARMACOKINETICS OF ETHYNYLESTRADIOL IN WOMEN USING RADIOIMMUNOASSAY [J].
BACK, DJ ;
BRECKENRIDGE, AM ;
CRAWFORD, FE ;
MACIVER, M ;
ORME, MLE ;
ROWE, PH ;
WATTS, MJ .
CONTRACEPTION, 1979, 20 (03) :263-273
[3]   THE RELATIVE BIOAVAILABILITY OF LEVONORGESTREL AND ETHINYLESTRADIOL WHEN ADMINISTERED IN TABLET AND CAPSULE FORM [J].
BACK, DJ ;
KILLICK, SR ;
STEVENSON, PJ ;
SHENOY, N ;
ELSTEIN, M ;
COHEN, M .
CONTRACEPTION, 1987, 36 (03) :321-326
[4]   RADIOIMMUNOASSAY OF UNCONJUGATED PLASMA ETHYNYLESTRADIOL IN WOMEN GIVEN A SINGLE ORAL DOSE OF ETHYNYLESTRADIOL OR MESTRANOL [J].
DELAPENA, A ;
CHENAULT, CB ;
GOLDZIEHER, JW .
STEROIDS, 1975, 25 (06) :773-780
[5]   BIOAVAILABILITY OF CONTRACEPTIVE STEROIDS FROM CAPSULES [J].
FOTHERBY, K ;
WARREN, RJ .
CONTRACEPTION, 1976, 14 (03) :261-267
[6]   PHARMACOKINETICS OF ETHYNYLOESTRADIOL IN WOMEN FROM DIFFERENT POPULATIONS [J].
FOTHERBY, K ;
AKPOVIRORO, J ;
ABDELRAHMAN, HA ;
TOPPOZADA, HK ;
DESOUZA, JC ;
COUTINHO, EM ;
KOETSAWANG, S ;
NUKULKARN, P ;
SHETH, UK ;
MAPA, MK ;
GOPALAN, S ;
PLUNKETT, ER ;
BRENNER, PF ;
HICKEY, MV ;
GRECH, ES ;
LICHTENBERG, R ;
GUAL, C ;
MOLINA, R ;
GOMEZROGERS, C ;
KWON, E ;
KIM, SW ;
CHAN, T ;
RATNAM, SS ;
LANDGREN, BM ;
SHEARMAN, RP ;
GOLDZIEHER, JW ;
DOZIER, TS .
CONTRACEPTION, 1981, 23 (05) :487-496
[7]  
HELTON ED, 1977, CONTRACEPTION, V15, P225
[8]   INVESTIGATIONS OF PHARMACOKINETICS OF ETHINYLESTRADIOL TO SPECIFIC CONSIDERATION OF A POSSIBLE 1ST-PASS EFFECT IN WOMEN [J].
HUMPEL, M ;
NIEUWEBOER, B ;
WENDT, H ;
SPECK, U .
CONTRACEPTION, 1979, 19 (04) :421-432
[9]  
JUNG-HOFFMANN C, 1989, Acta Endocrinologica Supplementum, V120, P169
[10]   PHARMACOKINETICS OF SINGLE AND MULTIPLE DOSES OF ETHINYL ESTRADIOL AND LEVONORGESTREL IN RELATION TO SMOKING [J].
KANARKOWSKI, R ;
TORNATORE, KM ;
DAMBROSIO, R ;
GARDNER, MJ ;
JUSKO, WJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1988, 43 (01) :23-31